EUVIMEDEUVIMED entdecken
Crossref

A Self-Immolative DNA Nanogel Vaccine toward Cancer Immunotherapy

Yuwei Hu iD, Shujun Gao, Hongfang Lu, Susi Tan, Feng Chen, Yujie Ke iD, Jackie Y Ying iD

Nano Letters · 2023

DOI: 10.1021/acs.nanolett.3c02449 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nano Letters, 2023. Verfasst von Yuwei Hu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Materials Research and Engineering (IMRE), Agency for Science, Technology and Research (A*STAR), 2 Fusionopolis Way, Innovis #08-03, Sin…. Hauptthemen laut MEDLINE: Vaccines, DNA, Neoplasms. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 71 Literaturangaben. Gefördert von: Agency for Science, Technology and Research, Science and Engineering Research Council, NanoBio Lab.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of precisely engineered vehicles for intracellular delivery and the controlled release of payloads remains a challenge. DNA-based nanomaterials offer a promising solution based on the A-T-G-C alphabet-dictated predictable assembly and high programmability. Herein, we present a self-immolative DNA nanogel vaccine, which can be tracelessly released in the intracellular compartments and activate the immune response. Three building blocks with cytosine-rich overhang domains are designed to self-assemble into a DNA nanogel framework with a controlled size. Two oligo agonists and one antigen peptide are conjugated to the building blocks via an acid-labile chemical linker. Upon internalization into acidic endosomes, the formation of i-motif configurations leads to dissociation of the DNA nanogel vaccine. The acid-labile chemical linker is cleaved, releasing the agonists and antigen in their traceless original form to activate antigen-presenting cells and an immune response. This study presents a novel strategy for constructing delivery platforms for intracellularly stimuli-triggered traceless release of therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vaccines, DNANeoplasmsHumansNanogelsImmunotherapyDNAPolyethylene GlycolsPolyethyleneimine

Stichwörter der Autor:innen

DNA nanogelacid-labileagonists and antigencancer therapyi-motif

Substanzen

NanogelsVaccines, DNADNApolyethylene glycol polyethyleneimine nanogelPolyethylene GlycolsPolyethyleneimine

Autor:innen und Institutionen

  • Institute of Materials Research and Engineering (IMRE), Agency for Science, Technology and Research (A*STAR), 2 Fusionopolis Way, Innovis #08-03, Singapore 138634, Republic of Singapore.
  • NanoBio Lab, Agency for Science, Technology and Research (A*STAR), 31 Biopolis Way, The Nanos, #09-01, Singapore 138669, Republic of Singapore.
  • A*STAR Infectious Diseases Laboratories, Agency for Science, Technology and Research (A*STAR), 31 Biopolis Way, The Nanos, #09-01, Singapore 138669, Republic of Singapore.
  • Bioengineering Department, King Fahd University of Petroleum and Minerals, Dhahran 31261, Saudi Arabia.

ORCID-Profile: Yuwei Hu, Yujie Ke, Jackie Y Ying

Förderung

  • Agency for Science, Technology and Research
  • Science and Engineering Research Council
  • NanoBio Lab
  • Health and Biomedical Sciences Industry Alignment Fund Pre-Positioning

Zitieren

APA

Hu, Y., Gao, S., Lu, H., Tan, S., Chen, F., Ke, Y., & Ying, J. Y. (2023). A Self-Immolative DNA Nanogel Vaccine toward Cancer Immunotherapy. Nano Letters. https://doi.org/10.1021/acs.nanolett.3c02449

Vancouver

Hu Y, Gao S, Lu H, Tan S, Chen F, Ke Y, et al. A Self-Immolative DNA Nanogel Vaccine toward Cancer Immunotherapy. Nano Letters. 2023. doi:10.1021/acs.nanolett.3c02449

BibTeX
@article{Hu2023,
  author = {Hu, Yuwei and Gao, Shujun and Lu, Hongfang and Tan, Susi and Chen, Feng and Ke, Yujie and Ying, Jackie Y},
  title = {A Self-Immolative DNA Nanogel Vaccine toward Cancer Immunotherapy},
  journal = {Nano Letters},
  year = {2023},
  doi = {10.1021/acs.nanolett.3c02449}
}
Kostenlos starten →